Biomarkers

Alzheimers Dement. 2024 Dec:20 Suppl 2:e090076. doi: 10.1002/alz.090076.

Abstract

Background: Speech variations appear at early stages of Alzheimer's disease (AD) and are potential early indicators. However, the commonly used neuropsychological assessment scales as screening tools for cognitive impairments have limitations due to possible subjective bias of the assessors and the lack of sensitivity in voice detection. We propose a solution based on machine learning for multi-dimensional feature extraction and data fusion of spontaneous speech signals.

Method: Participates with gold standard diagnosis including cognitively normal, mild cognitive impairment (MCI), and mild AD underwent a speech-based cognitive assessment (Shanghai Cognitive Screening, SCS), including picture learning and recall tasks. Their voice data were generated and created into semantic datasets and audio datasets, respectively. Then, to obtain semantic and acoustic features, the two datasets were trained in multiple machine learning models and tested separately. Finally, to separating cognitively normal and impaired (MCI+AD) participants, multi-dimensional features of the speech signal are combined through data fusion using voting style.

Result: The accuracy of this model is 91.5 ± 0.8%, with a specificity of 97.0%. In addition, there are significant differences between cognitively impaired patients and normal controls regarding instant recall as opposed to delayed recall tasks, with the most notable difference being the duration of silence in delayed recall tasks.

Conclusion: This method maximizes the exploration of feature information in speech signals, greatly improving the accuracy of identification for Alzheimer's disease.

MeSH terms

  • Aged
  • Alzheimer Disease* / diagnosis
  • Biomarkers*
  • Cognitive Dysfunction* / diagnosis
  • Female
  • Humans
  • Machine Learning*
  • Male
  • Neuropsychological Tests / statistics & numerical data
  • Sensitivity and Specificity
  • Speech*

Substances

  • Biomarkers